Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
COCP
#3809
Cocrystal Pharma, Inc. Common Stock
1.0
4
-2.80%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
-2.80%
Aylık değişim
0.00%
6 aylık değişim
-31.58%
Yıllık değişim
-40.23%
Önceki kapanış
1.0
7
Open
1.0
2
Bid
Ask
Low
1.0
2
High
1.0
4
Hacim
7
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
COCP
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
5.96 M
8.12 M
8.14 M
10.17 M
10.17 M
—
Valuation ratios
Enterprise value
—
—
-20.2 M
-8.47 M
10.69 M
38.24 M
Price to earnings ratio
—
—
-0.44
-0.94
-1.17
-4.64
Price to sales ratio
—
—
945.49
-260.99
-126.08
-350.54
Price to cash flow ratio
—
—
-0.79
-1.16
-1.25
-4.68
Price to book ratio
—
—
0.43
0.64
2.16
3.33
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.18
-0.18
-0.95
-0.58
1.3
0.46
Return on equity %
0.18
-0.18
-0.98
-0.68
1.84
0.68
Return on invested capital %
186.85
—
1 324.77
2 801.62
2 921.49
—
Gross margin %
100
—
100
100
100
400
Operating margin %
475.97
—
215.72 K
-28.55 K
-10.97 K
96.7 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
479.05
—
-215.76 K
27.67 K
-10.74 K
-58.48 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
25.05
38.4
33.04
8.92
4.77
18.81
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.05
0
0
-0
-0.01
-0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-2.63
-1.52
1.62
-0.31
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
4.57
2.73
0.97
2.82
Net current asset value per share
—
—
4.93
3.01
1.14
3.47
Tangible book value per share
—
—
4.86
2.73
0.94
2.88
Working capital per share
—
—
4.78
2.68
0.9
2.72
Book value per share
—
—
4.86
2.73
0.94
2.88
Haberler
Cocrystal Pharma norovirüs ilaç adayını Faz 1b denemesine ilerletiyor
Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial
Tuesday’s Insider Activity: Major Buys at CBC, COCP; Sells at ARES, RKLB
Phillip Frost, Cocrystal Pharma (COCP) hisselerinden 18.812 dolar değerinde satın aldı
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812
Cocrystal Pharma yöneticilerinden özel yerleşimle 1,03 milyon dolar topladı
Cocrystal Pharma raises $1.03 million in private placement from directors
Cocrystal Pharma receives $500,000 NIH grant for influenza drug
Cocrystal Pharma 4,7 milyon dolarlık kayıtlı doğrudan teklifini tamamladı
Cocrystal Pharma closes $4.7 million registered direct offering
Cocrystal Pharma, piyasada doğrudan hisse arzıyla 4,7 milyon dolar topladı
Cocrystal Pharma raises $4.7 million in registered direct offering